Immunogenicity of ChAdOx1 nCoV-19 Booster Vaccination Following Two CoronaVac Shots in Healthcare Workers

During the early phase of the COVID-19 pandemic, several countries, including Thailand, provided two shots of CoronaVac to healthcare workers. Whereas ChAdOx1 nCoV-19 is the promising vaccine as the booster dose, the data on immunogenicity when administered after CoronaVac have been limited. The pur...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Wisit Prasithsirikul, Krit Pongpirul, Tanawin Nopsopon, Phanupong Phutrakool, Wannarat Pongpirul, Chatpol Samuthpongtorn, Pawita Suwanwattana, Anan Jongkaewwattana
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2022-01-01
Serie:	Vaccines
Soggetti:	COVID-19 SARS-CoV-2 vaccines immunogenicity ChAdOx1 CoronaVac
Accesso online:	https://www.mdpi.com/2076-393X/10/2/217
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!